Production and characterization of γ-polyglutamic acid nanoparticles for controlled anticancer drug release

Critical Reviews in Biotechnology

Volumn 28, Issue 2, 2008, Pages 83-99

  Manocha, Bhavik ^a   Margaritis, Argyrios ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

polyglutamic acid (PGA); Biomaterial; Biopolymer; Cancer chemotherapy; Drug delivery; Nanoparticles; Polyglutamic acid

Indexed keywords

BIOCOMPATIBILITY; BIOLOGICAL MATERIALS; DIFFERENTIAL AMPLIFIERS; DRUG DELIVERY; DRUG DOSAGE; HEALTH; NANOPARTICLES; NANOSTRUCTURED MATERIALS; NANOSTRUCTURES; POLYMERS; PROGRAMMED CONTROL SYSTEMS;

ANTI CANCER DRUGS; BIOLOGICAL PROPERTIES; CANCER CHEMOTHERAPIES; DRUG DELIVERY APPLICATIONS; DRUG DELIVERY CARRIERS; MICROBIAL SPECIES; NON-TOXICITY; POLY(GLUTAMIC ACID); TARGETED DRUG DELIVERY; TUMOR PHYSIOLOGY;

CHEMOTHERAPY;

BIOPOLYMER; CLONAZEPAM; CREMOPHOR; DIMETHYL SULFOXIDE; DOXORUBICIN; FIBROBLAST GROWTH FACTOR; GAMMA POLYGLUTAMIC ACID; INDINAVIR; INSULIN; MACROGOL; N,N DIMETHYLFORMAMIDE; NANOPARTICLE; OPSONIN; OVALBUMIN; PACLITAXEL; PACLITAXEL POLIGLUMEX; POLYGLUTAMIC ACID; VASCULOTROPIN;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; CANCER CHEMOTHERAPY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; HUMAN; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RETICULOENDOTHELIAL SYSTEM; REVIEW; SUSTAINED RELEASE FORMULATION;

ANIMALS; ANTINEOPLASTIC AGENTS; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; HUMANS; NANOPARTICLES; NEOPLASMS; PARTICLE SIZE; POLYGLUTAMIC ACID;

BACILLACEAE;

EID: 45849116568     PISSN: 07388551     EISSN: 15497801     Source Type: Journal    
DOI: 10.1080/07388550802107483     Document Type: Review

References (100)

1. Akagi, T., Kaneko, T., Kida, T., and Akashi, M. 2005. Preparation and characterization of biodegradable nanoparticles based on poly([gamma]-glutamic acid) with l-phenylalanine as a protein carrier. J Control. Release. 108: 226-236.
2. Akagi, T., Kaneko, T., Kida, T., and Akashi, M. 2006. Multifunctional conjugation of proteins on/into bio-nanoparticles prepared by amphiphilic poly(gamma-glutamic acid). J. Biomat. Sci. Polym. Ed. 17: 875-892.
3. Albain, K. S., Belani, C. P., Bonomi, P., O'Byrne, K. J., Schiller, J. H., and Socinski, M. 2006. PIONEER: A phase III randomized trial of paclitaxel poliglumex versus paclitaxel in chemotherapy-naive women with advanced-stage non-small-cell lung cancer performance status of 2. Clin. Lung Cancer 7: 417-419.
4. Allemann, E., Gravel, P., Leroux, J. C., Balant, L., and Gurny, R. 1997. Kinetics of blood component adsorption on poly(D,L-lactic acid) nanoparticles: evidence of complement C3 component involvement. J. Biomed. Mater. Res. 37: 229-234.
5. Altundag, K., Dede, D. S., and Purnak, T. 2007. Albumin-bound paclitaxel (ABI-007; Abraxane) in the management of basal-like breast carcinoma. J. Clin. Pathol. 60: 958.
6. Ashiuchi, M., Kamei, T., Baek, D. H., Shin, S. Y., Sung, M. H., Soda, K., Yagi, T., and Misono, H. 2004. Enzymatic synthesis of high molecular weight poly-gamma-glutamate and regulation of its stereochemistry. Appl. Environ. Microbiol. 70: 4249-4255.
7. Au, J. L. S., Jang, S. H., and Wientjes, M. G. 2002. Clinical aspects of drug delivery to tumors. J. Control. Release 1-3: 81-95.
8. Auzenne, E., Donato, N. J., Li, C., Leroux, E., Price, R. E., Farquhar, D., and Klostergaard, J. 2002. Superior therapeutic profile of poly-L-glutamic acid-paclitaxel copolymer compared with Taxol in xenogenic compartmental models of human ovarian carcinoma. Clin. Cancer Res. 8: 573-581.
9. Bala, I., Hariharan, S., and Ravi Kumar, M. N. V. 2004. PLGA nanoparticles in drug delivery: the state of the art. Crit. Rev. Ther. Drug Carrier Syst. 21(5): 387-422.
10. Bhadra, D., Bhadra, S., Jain, P., and Jain, N. K. 2002. Pegnology: a review of PEG-ylated systems. Pharmazie. 57: 5-29.
11. Brannon-Peppas, L., and Blanchette, J. O. 2004. Nanoparticle and targeted systems for cancer therapy. Adv. Drug Deliv. Rev. 56: 1649-1659.
12. Brigger, I., Dubernet, C., and Couvreur, P. 2002. Nanoparticles in cancer therapy and diagnosis. Adv. Drug Deliv. Rev. 54: 631-651.
13. Buescher, J. M., and Margaritis, A. 2007. Microbial biosynthesis of polyglutamic acid biopolymer and applications in the biopharmaceutical, biomedical and food industries. Crit. Rev. Biotechnol. 27: 1-19.
14. Butler, M. 1996. Animal Cell Culture and Technology. Oxford: IRL Press.
15. Calvo, P., Remunan-Lopez, C., Vila-Jato, J. L., and Alonso, M. J. 1997a. Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines. Pharm. Res. 14: 1431-1436.
16. Calvo, P., Remunan-Lopez, C., Vila-Jato, J. L., and Alonso, M. J. 1997b. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J. Appl. Polymer Sci. 63: 125-132.
17. Chari, R. V. J. 1998. Targeted delivery of chemotherapeutics: tumor activated pro-drug therapy. Adv. Drug Deliv. Rev. 31: 89-104.
18. Chen, Y., McCulloch, R. K., and Gray, B. N. 1994. Synthesis of albumin-dextran sulfate microspheres possessing favourable loading and release characteristics for the anti-cancer drug doxorubicin. J. Control. Release 31: 49-54.
19. Chen, Y., Mohanraj, V. J., and Parkin, J. E. 2003. Chitosan-dextran sulfate nanoparticles for delivery of an antiangiogenesis peptide. Lett. Pep. Sci. 10: 621-627.
20. Cho, C. S., Jeong, Y. I., Ishihara, T., Takei, R., Park, J. U., Park, K. H, Maruyama, A., and Akaike, T. 1997. Simple preparation of nanoparticles coated with carbohydrate-carrying polymers. Biomaterials 18: 323-326.
21. Cho, C. S., Kobayashi, A., Takei, R., Ishihara, T., Maruyama, A., and Akaike, T. 2001. Receptor-mediated cell modulator delivery to hepatocyte using nanoparticles coated with carbohydrate-carrying polymers. Biomaterials. 22: 45-51.
22. Chognot, D., Six, J. L., Leonard, M., Bonneaux, F., Vigneron, C., and Dellacherie, E. 2003. Physicochemical evaluation of PLA nanoparticles stabilized by water-soluble MPEO-PLA block copolymers. J. Colloid Interface Sci. 268: 441-447.
23. Dipetrillo, T., Milas, L., Evans, D., Akerman, P., Ng, T., Miner, T., Cruff, D., Chauhan, B., Iannitti, D., Harrington, D., and Safran, H. 2006. Paclitaxel poliglumex (PPX-Xyotax) and concurrent radiation for esophageal and gastric cancer: a phase I study. Am. J. Clin. Oncol. 29: 376-379.
24. Dunne, M., Corrigan, O. I., and Ramtoola, Z. 2000. Influence of particle size and dissolution conditions on the degradation properties of polylactide-co-glycolide particles. Biomaterials. 21: 1659-1668.
25. Edde, B., Rossier, J., Le Xaer, J. P., Desbruyeres, E., Gros, F., and Denoulet, P. 1990. Posttranslational glutamylation of alpha-tubulin. Science 247: 83-85.
26. Felt, O., Buri, P., and Gurny, R. 1998. Chitosan: a unique polysaccharide for drug delivery. Drug Dev. Ind. Pharm. 24: 979-993.
27. Feng, S., and Chien, S. 2003. Chemotherapeutic engineering: application and further development of chemical engineering principles for chemotherapy of cancer and other diseases. Chem. Eng. Sci. 58: 4087-4114.
28. Feng, S., and Huang, G. 2001. Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers. J. Control. Release. 71: 53-69.
29. Ferrari, M. 2005. Cancer nanotechnology: opportunities and challenges. Nat. Rev. Cancer 5: 161-171.
30. Fresta, M., Puglisi, G., Giammona, G., Cavallaro, G., Micali, N., and Furneri, P. M. 1995. Pefloxacin mesilate- and ofloxacin loaded polyethylcyanoacrylate nanoparticles: characterization of the colloidal drug carrier formulation. J. Pharm. Sci. 84: 895-902.
31. Garlotta, D. 2001. A literature review of poly(lactic acid). J. Polym. Environ. 9(22): 63-84.
32. Gelderblom, H., Verweij, J., Nooter, K., and Sparreboom, A. 2001. Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. Eur. J. Cancer. 37: 1590-1598.
33. Gordon, S. 1995. The macrophage. Bioessays. 17: 977-986.
34. Govender, T., Riley, T., Ehtezazi, T., Garnett, M. C., Stolnik, S., Illum, L., and Davis, S. S. 2000. Defining the drug incorporation properties of PLA-PEG nanoparticles. Int. J. Pharm. 199: 95-110.
35. Govender, T., Stolnik, S., Garnett, M. C., Illum, L., and Davis, S. S. 1999. PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J. Control. Release. 57: 171-185.
36. Heiati, H., Tawashi, R., Shivers, R. R., and Phillips, N. C. 1997. Solid lipid nanoparticles as drug carriers I. Incorporation and retention of the lipophilic pro-drug 3′-azido-3′-deoxythymidine palmitate. Int. J. Pharm. 146: 123-131.
37. Hezayen, F., Rehm, B., Tindall, B., and Steinbuchel, A. 2001. Transfer of Natrialba asiatica B1T to Natrialba taiwanensis sp. nov. and description of Natrialba aegyptiaca sp. nov., a novel extremely halophilic, aerobic, non-pigmented member of the Archaea from Egypt that produces extracellular poly(glutamic acid). Int. J. Syst. Evol. Microbiol. 51: 1133-1142.
38. Higashi, N., Shosu, T., Koga, T., Niwa, M., and Tanigawa, T. 2006. pH-responsive, self-assembling nanoparticle from a fullerene-tagged poly(L-glutamic acid) and its superoxide dismutase mimetic property. J. Colloid Interface Sci. 298: 118-123.
39. Hilgenbrink, A. R., and Low, P. S. 2005. Folate receptor-mediated drug targeting: from therapeutics to diagnostics. J. Pharm. Sci. 94: 2135-2146.
40. Hitzman, C. J., Elmquist, W. F., and Wiedmann, T. S. 2006a. Development of a respirable, sustained release microcarrier for 5-fluorouracil II: in vitro and in vivo optimization of lipid coated nanoparticles. J. Pharm. Sci. 95: 1127-1143.
41. Hitzman, C. J., Wattenberg, L. W., and Wiedmann, T. S. 2006b. Pharmacokinetics of 5-fluorouracil in the hamster following inhalation delivery of lipid-coated nanoparticles. J. Pharm. Sci. 95: 1196-1211.
42. Hoste, K., Schacht, E., and Seymour, L. 2000. Newderivatives of polyglutamic acid as drug carrier systems. J. Control. Release 64: 53-61.
43. Jain, R. K. 1988. Determinants of tumor blood flow: a review. Cancer Res. 48: 2641-2658.
44. Jain, R. K. 1989. Delivery of novel therapeutic agents in tumors: physiological barrier and strategies. J. Natl. Cancer Inst. 81: 570-576.
45. Jain, R. K. 1999. Transport of molecules, particles, and cells in solid tumors. Annu. Rev. Biomed. Eng. 1: 241-263.
46. Jeong, Y., Cheon, J., Kim, S., Nah, J., Lee, Y., Sung, Y., Akaike, T., and Cho, C. 1998. Clonazepam release from core-shell type nanoparticles in vitro. J. Control. Release. 51: 169-178.
47. Jeong, Y., Seo, S., Park, I., Lee, H., Kang, I., Akaike, T., and Cho, C. 2005. Cellular recognition of paclitaxel-loaded polymeric nanoparticles composed of poly(gamma-benzyl L-glutamate) and poly(ethylene glycol) diblock copolymer endcapped with galactose moiety. Int. J. Pharm. 296: 151-161.
48. Jeong, Y. I., Nah, J.W., Lee, H. C., Kim, S. H., and Cho, C. S. 1999. Adriamycin release from flower-type polymeric micelle based on starblock copolymer composed of poly(gamma-benzyl L-glutamate) as the hydrophobic part and poly(ethylene oxide) as the hydrophilic part. Int. J. Pharm. 188: 49-58.
49. Jones, A., and Harris, A. L. 1998. New developments in angiogenesis: a major mechanism for tumor growth and target for therapy. Cancer J. Sci. Am. 4: 209-217.
50. Kaszuba, M. 1999. The measurement of nanoparticles using photon correlation spectroscopy and avalanche photo diodes. J. Nanoparticle Res. 1: 405-409.
51. Kingsley, J., Dou, H., Morehead, J., Rabinow, B., Gendelman, H., and Destache, C. 2006. Nanotechnology: a focus on nanoparticles as a drug delivery system. J. NeuroImmune Pharmacol. 1: 340-350.
52. Koizumi, F., Kitagawa, M., Negishi, T., Onda, T., Matsumoto, S., Hamaguchi, T., and Matsumura, Y. 2006. Novel SN-38-incorporating polymeric micelles, NK012, eradicate vascular endothelial growth factor-secreting bulky tumors. Cancer Res. 66: 10048-10056.
53. Kumar, M. N. V. R. 2000. Nano and microparticles as controlled drug delivery devices. J. Pharm. Sci. 3: 234-258.
54. Kumar, M. N. V. R., Sameti, M., Kneuer, C., Lamprecht, A., and Lehr, C. M. 2004. Polymeric nanoparticles for drug and gene delivery. Encycl. Nanosci. Nanotechnol. 9: 1-19.
55. Kumar, N., Ravikumar, M. N. V., and Domb, A. J. 2001. Biodegradable block copolymers. Adv. Drug Deliv. Rev. 53: 23-44.
56. Kunioka, M. 1997. Biosynthesis and chemical reactions from poly(amino acid)s from microorganisms. Appl. Microbiol. Biotechnol. 47: 469-475.
57. Liang, H., Yang, T., Huang, C., Chen, M., and Sung, H. 2005. Preparation of nanoparticles composed of poly([gamma]-glutamic acid)-poly(lactide) block copolymers and evaluation of their uptake by HepG2 cells. J. Control. Release. 105: 213-225.
58. Lin, Y., Chung, C., Chen, C., Liang, H., Chen, S., and Sung, H. 2005. Preparation of nanoparticles composed of chitosan/poly-gamma-glutamic acid and evaluation of their permeability through Caco-2 cells. Biomacromolecules. 6: 1104-1112.
59. Lin, Y., Mi, F., Chen, C., Chang, W., Peng, S., Liang, H., and Sung, H. 2007a. Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery. Biomacromolecules. 8: 146-152.
60. Lin, Y. H., Chen, C. T., Liang, H. F., Kulkarni, A. R., Lee, P.W., Chen, C. F., and Sung, H. 2007b. Novel nanoparticles for oral insulin delivery via the paracellular pathway. Nanotechnology. 18: 105-102.
61. Links, M., and Brown, R. 1999. Clinical relevance of the molecular mechanisms of resistance to anticancer drugs. Expert Rev. Mol. Med. 1: 1-21.
62. Magenheim, B., Levy, M. Y., and Benita, S. 1993. A new in vitro technique for the evaluation of drug release profile from colloidal carriers - ultrafiltration technique at low pressure. Int. J. Pharm. 94: 115-123.
63. Man, M., and Rugo, H. 2005. Paclitaxel poliglumex (Cell Therapeutics/ Chugai Pharmaceutical). IDrugs. 8: 739-754.
64. Minchinton, A. I., and Tannock, I. F. 2006. Drug penetration in solid tumors. Nat. Rev. Cancer. 6: 583-592.
65. Moghimi, S. M., Hunter, A. C., and Murray, J.C. 2001. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol. Rev. 53: 283-318.
66. Moghimi, S. M., Hunter, A. C., and Murray, J. C. 2005. Nanomedicine: current status and future prospects. FASEB J. 19: 311-330.
67. Mohanraj, V. J., and Chen, Y. 2006. Nanoparticle - a review. Trop. J. Pharm. Res. 5: 561-573.
68. Niemetz, R., Karcher, U., Kandler, O., Tindall, B. J., and Konig, H. 1997. The cell wall polymer of extremely halophilic archaeon Natronococcus occultus. Eur. J. Biochem. 249: 905-911.
69. Oldham, E., Li, C., Ke, S., Wallace, S., and Huang, P. 2000. Comparison of action of paclitaxel and poly(L-glutamic acid)-paclitaxel conjugate in human breast cancer cells. Int. J. Oncol. 16: 125-132.
70. Panyam, J., Dali, M. M., Sahoo, S. K., Ma, W., Chakravarthi, S. S., Amidon, G. L., Levy, R. J., and Labhasetwar, V. 2003. Polymer degradation and in vitro release of a model protein from poly(L-lactide-co-glycolide) nano- and microparticles. J. Control. Release. 92: 173-187.
71. Panyam, J., Williams, D., Dash, A., Leslie-Pelecky, D., and Labhasetwar, V. 2004. Solid-state solubility influences encapsulation and release of hydrophobic drugs from PLGA/PLA nanoparticles. J. Pharm. Sci. 93: 1804-1814.
72. Peppas, L. B. 1995. Recent advances in the use of biodegradable microparticles and nanoparticles in the controlled drug delivery. Int. J. Pharm. 116: 1-9.
73. Peppas, N. A. 1984. Mathematical modelling of diffusion processes in drug delivery polymeric systems. In Medical Applications of Controlled Release Technology, 169-187. Langer, R. S., and Wide, D., eds. CRC Press, Boca Raton, FL.
74. Peracchia, M., Gref, R., Minamitake, Y., Domb, A., Lotan, N., and Langer, R. 1997. PEG-coated nanospheres from amphiphilic diblock and multiblock copolymers: investigation of their drug encapsulation and release characteristics. J. Control. Release. 46: 223-231.
75. Polakovic, M., Gorner, T., Gref, R., and Dellacherie, E. 1999. Lidocaine-loaded biodegradable nanospheres. II. Modeling of drug release. J. Control. Release. 60: 169-177.
76. Poznansky, M., and Juliane, R. L. 1984. Biological approaches to the controlled delivery of drugs: a critical review. Pharmacol. Rev. 36: 277-336.
77. Redhead, H. M., Davis, S. S., and Illum, L. 2001. Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation. J. Control. Release. 70: 353-363.
78. Reis, C. P., Neufeld, R. J., Ribeiro, A. J., and Veiga, F. 2006. Nanoencapsulation I: methods for preparation of drug-loaded polymeric nanoparticles. Nanomedicine. 2: 8-21.
79. Richard, A., and Margaritis, A. 2001. Poly(glutamic acid) for biomedical applications.Crit. Rev. Biotechnol. 21: 219-232.
80. Richard, A., and Margaritis, A. 2003a. Rheology, oxygen transfer, and molecular weight characteristics of poly(glutamic acid) fermentation by Bacillus subtilis. Biotech. Bioeng. 82(3): 299-305.
81. Richard, A., and Margaritis, A. 2003b. Optimization of cell growth and poly(glutamic acid) production in batch fermentation by Bacillus subtilis. Biotechnol. Lett. 25: 465-468.
82. Richard, A., and Margaritis, A. 2004. Empirical modeling of batch fermentation kinetics for poly(glutamic acid) production and other microbial biopolymers. Biotech. Bioeng. 87: 501-515.
83. Richard, A., and Margaritis, A. 2006. Kinetics of molecular weight reduction of poly(glutamic acid) by in situ depolymerization in cell-free broth of Bacillus subtilis. Biochem. Eng. J. 30: 303-307.
84. Sahli, H., Tapon-Bretaudiere, J., Fischer, A. M., Sternberg, C., Spenlehauer, G., Verrecchia, T., and Labarre, D. 1997. Interactions of poly(lactic acid) and poly(lactic acid-co-ethylene oxide) nanoparticles with the plasma factors of the coagulation system. Biomaterials 18: 281-288.
85. Shih, I. L., Van, Y. T., Yeh, L. C., Lin, H. G., and Chang, Y. N. 2001. Production of a biopolymer flocculent from Bacillus licheniformis and its flocculation properties. Bioresour. Technol. 78: 267-272.
86. Singer, J. W. 2005. Paclitaxel poliglumex (XYOTAX, CT-2103) a macromolecular taxane. J. Control. Release. 109: 120-126.
87. Singer, J. W., Shaffer, S., Baker, B., Bernareggi, A., Stromatt, S., Nienstedt, D., and Besman, M. 2003. Poly-(L)-glutamic acid-paclitaxel (CT-2103) [XYOTAX], a biodegradable polymeric drug conjugate: characterization, preclinical pharmacology, and preliminary clinical data. Adv. Exp. Med. Biol. 519: 81-99.
88. Sledge, G., and Miller, K. 2003. Exploiting the hallmarks of cancer: the future conquest of breast cancer. Eur. J. Cancer. 39: 1668-1675.
89. Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., and Rudzinski, W. E. 2001. Biodegradable polymeric nanoparticles as drug delivery devices. J. Control. Release. 70: 1-20.
90. Storm, G., Belliot, S. O., Daemen, T., and Lasic, D. 1995. Surface modification of nanoparticles to oppose uptake by mononuclear phagocyte system. Adv. Drug Deliv. Rev. 17: 31-48.
91. Sudimack, J., and Lee, R. J. 2000. Targeted delivery via folate receptor. Adv. Drug Deliv. Rev. 41: 147-162.
92. Tonnesen, H. H., and Karlsen, J. 2002. Alginate in drug delivery systems. Drug Dev. Ind. Pharm. 28: 621.
93. Troy, F. A. 1973. Chemistry and biosynthesis of poly(gamma-D-glutamyl) capsule in Bacillus licheniformis. 1. Properties of the membrane mediated biosynthesis reaction. J. Biol. Chem. 248: 305-316.
94. Vila, A., Sánchez, A., Tobío, M., Calvo, P., and Alonso, M. J. 2002. Design of biodegradable particles for protein delivery.J. Control. Release. 78: 15-24.
95. Vittaz, M., Bazile, D., Spenlehauer, G., Verrecchia, T., Veillard, M., Puisieux, F., and Labarre, D. 1996. Effect of PEO surface density on long-circulating PLA-PEO nanoparticles which are very low complement activators. Biomaterials. 17: 1575-1581.
96. Washington, C. 1990. Drug release from microdisperse systems: a critical review. Int. J. Pharm. 58: 1-12.
97. Weber, J. 1990. Poly(gamma-glutamic acid)s are the major constituents of nematocysts in Hydra (Hydrozoa, Cnidaria). J. Biol. Chem. 265: 9664-9669.
98. Weir, D. M. 1983. Immunology - An Outline for Students of Medicine and Biology. Churchill Livingstone, Edinburg, UK.
99. Yang, S. C., Lu, L. F., Cai, Y., Zhu, J. B., Liang, B. W., and Yang, C. Z. 1999. Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. J. Control. Release. 59: 299-307.
100. Yoon, S. H., Hwan Do, J., Lee, S. Y., and Nam Chang, H. 2000. Production of poly-gamma-glutamic acid by fed-batch culture of Bacillus licheniformis. Biotechnol. Lett. 22: 585-588.